Effects of continuous intravenous infusion of MCI-186 on functional recovery after spinal cord injury in rats

Journal of Neurotrauma

Volumn 28, Issue 2, 2011, Pages 289-298

  Ohta, Souichi ^a   Iwashita, Yasushi ^b   Kakinoki, Ryosuke ^a   Noguchi, Takashi ^a   Nakamura, Takashi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UTANO NATIONAL HOSPITAL   (Japan)

Author keywords

antioxidants; locomotor function; rat; recovery; spinal cord injury

Indexed keywords

LIPID PEROXIDE; MALONALDEHYDE; NORPHENAZONE; THIOBARBITURIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CONVALESCENCE; DOSE RESPONSE; DRUG EFFECT; HISTOLOGY; IN VIVO STUDY; LIPID PEROXIDATION; LOCOMOTION; MALE; MOTOR PERFORMANCE; NEUROPROTECTION; NONHUMAN; RAT; SPINAL CORD INJURY;

ANIMALS; ANTIPYRINE; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; FREE RADICAL SCAVENGERS; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 79951701207     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2010.1477     Document Type: Article

References (35)

1. Allen, A.R. (1914). Remarks on the histopathological changes in the spinal cord due to impact. An experimental study. J. Nerv. Ment. Dis. 41, 141-147.
2. Ando, K., Nishi, H., Watanabe, T., Watanabe, Y., Yuki, S., Sugasawa, K., Horii, D., Ishibashi, A., Kimura, A., Nakano, D., and Morinaga, T. (1997). General pharmacological studies of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), a novel radical scavenging agent. Jpn. Pharmacol. Ther. 25, 1723-1753.
3. Basso, D.M., Beattie, M.S., and Bresnahan, J.C. (1995). A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1-21.
4. Behrmann, D.L., Bresnahan, J.C., and Beattie, M.S. (1993). A comparison of YM-14673, U-50488H, and nalmefene after spinal cord injury in the rat. Exp. Neurol. 119, 258-267. (Pubitemid 23132023)
5. Behrmann, D.L., Bresnahan, J.C., and Beattie, M.S. (1994). Modeling of acute spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone, U- 74006F and YM-14673. Exp. Neurol. 126, 61-75. (Pubitemid 24131103)
6. Bracken, M.B., Shepard, M.J., Holford, T.R., Leo-Summers, L., Aldrich, E.F., Fazl, M., Fehlings, M.G., Herr, D.L., Hitchon, P.W., Marshall, L.F., Nockels, R.P., Pascale, V., Perot, P.L., Jr., Piepmeier, J., Sonntag, V.K., Wagner, F., Wilberger, J.E., Winn, H.R., and Young, W. (1998). Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J. Neurosurg. 89, 699-706. (Pubitemid 28485526)
7. Braughler, J.M., and Hall, E.D. (1982). Correlation of methylprednisolone levels in cat spinal cord with its effects on (Na++K+)-ATPase, lipid peroxidation, and alpha motor neuron function. J. Neurosurg. 56, 838-844. (Pubitemid 12045514)
8. Bresnahan, J.C., Beattie, M.S., Todd, F.D., 3rd, and Noyes, D.H. (1987). A behavioral and anatomical analysis of spinal cord injury produced by a feedback-controlled impaction device. Exp. Neurol. 95, 548-570. (Pubitemid 17046222)
9. Demopoulos, H.B., Flamm, E.S., Seligman, M.L., Pietronigro, D.D., Tomasula, J., and DeCrescito, V. (1982). Further studies on free-radical pathology in the major central nervous system disorders: effect of very high doses of methylprednisolone on the functional outcome, morphology, and chemistry of experimental spinal cord impact injury. Can. J. Physiol. Pharmacol. 60, 1415-1424. (Pubitemid 13209547)
10. Edaravone Acute Infarction Study Group. (2003). Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, doubleblind study at multicenters. Cerebrovasc. Dis. 15, 222-229.
11. Fried, L.C., and Goodkin, R. (1971). Microangiographic observations of the experimentally traumatized spinal cord. J. Neurosurg. 35, 709-714.
12. Gruner, J.A. (1992). A monitored contusion model of spinal cord injury in the rat. J. Neurotrauma 9, 123-126; discussion 126-128.
13. Hall, E.D., and Braughler, J.M. (1981). Acute effects of intravenous glucocorticoid pretreatment on the in vitro peroxidation of cat spinal cord tissue. Exp. Neurol. 73, 321-324. (Pubitemid 11039791)
14. Hall, E.D. (1995). Inhibition of lipid peroxidation in central nervous system trauma and ischemia. J. Neurol. Sci. 134, 79-83.
15. Hall, E.D. (1992). The neuroprotective pharmacology of methylprednisolone. J. Neurosurg. 76, 13-22.
16. Hall, E.D., Yonkers, P.A., Andrus, P.K., Cox, J.W., and Anderson, D.K. (1992). Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury. J. Neurotrauma 9(Suppl. 2), S425-S442.
17. Kawai, H., Nakai, H., Suga, M., Yuki, S., Watanabe, T., and Saito, K.I. (1997). Effects of a novel free radical scavenger, MCI-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J. Pharmacol. Exp. Ther. 281, 921-927. (Pubitemid 27203828)
18. Komatsu, T., Nakai, H., Masaki, K., Obata, R., Nakai, K., and Iida, S. (1996). Pharmacokinetic studies of 3-methyl-1-phenyl- 2-pyrazolin-5-one (MCI-186) in rats (1): blood and plasma levels, distribution, metabolism and excretion after a single intravenous administration. Drug Metab. Pharmacokinet. 11, 463-480.
19. Kubo, K., Nakao, S., Jomura, S., Sakamoto, S., Miyamoto, E., Xu, Y., Tomimoto, H., Inada, T., and Shingu, K. (2009). Edaravone, a free radical scavenger, mitigates both gray and white matter damages after global cerebral ischemia in rats. Brain Res. 1279, 139-146.
20. Lu, J., Ashwell, K.W., and Waite, P. (2000). Advances in secondary spinal cord injury: role of apoptosis. Spine 25, 1859-1866. (Pubitemid 30469668)
21. Mattson, M.P. (1998). Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci. 21, 53-57. (Pubitemid 28078902)
22. Murota, S., Morita, I., and Suda, N. (1990). The control of vascular endothelial cell injury. Ann. NY Acad. Sci. 598, 182-187.
23. Nishi, H., Watanabe, T., Sakurai, H., Yuki, S., and Ishibashi, A. (1989). Effect of MCI-186 on brain edema in rats. Stroke 20, 1236-1240. (Pubitemid 19226920)
24. Ohta, S., Iwashita, Y., Takada, H., Kuno, S., and Nakamura, T. (2005). Neuroprotection and enhanced recovery with edaravone after acute spinal cord injury in rats. Spine (Phila Pa 1976) 30, 1154-1158. (Pubitemid 40695925)
25. Shibata, H., Arai, S., Izawa, M., Murasaki, M., Takamatsu, Y., Izawa, O., Takahashi, C., and Tanaka, M. (1998). Phase III clinical study of MCI-186 (Edaravone, 3-methyl-1-phenyl-2- pyrazolin-5-one) in healthy volunteers: safety and pharmacokinetics of single and multiple administrations. Jpn. J. Clin. Pharmacol. Ther. 29, 863-876. (Pubitemid 37070093)
26. Smith, P.K., Krohn, R.I., Hermanson, G.T., Mallia, A.K., Gartner, F.H., Provenzano, M.D., Fujimoto, E.K., Goeke, N.M., Olson, B.J., and Klenk, D.C. (1985). Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85. (Pubitemid 16258399)
27. Takamatsu, Y., and Watanabe, T. (1997). Studies on the concentrations of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186) in dog plasma and cerebral spinal fluid. Jpn. J. Clin. Pharmacol. Ther. 25(Suppl.), 1793-1797.
28. Takamatsu, Y., Yuki, S., and Watanabe, T. (1997). Studies on the concentration of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI- 186) in MCA occlusion and reperfusion model of rats. Jpn. Pharmacol. Ther. 25, 1785-1791.
29. Tanahashi, N., and Fukuuchi, Y. (2002). Treatment of acute ischemic stroke: recent progress. Intern. Med. 41, 337-344. (Pubitemid 34746175)
30. Tator, C.H., and Fehlings, M.G. (1991). Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 75, 15-26.
31. Tator, C.H. (1995). Update on the pathophysiology and pathology of acute spinal cord injury. Brain Pathol. 5, 407-413.
32. Vagnozzi, R., Marmarou, A., Tavazzi, B., Signoretti, S., Di Pierro, D., del Bolgia, F., Amorini, A.M., Fazzina, G., Sherkat, S., and Lazzarino, G. (1999). Changes of cerebral energy metabolism and lipid peroxidation in rats leading to mitochondrial dysfunction after diffuse brain injury. J. Neurotrauma 16, 903-913. (Pubitemid 29491762)
33. Watanabe, T., Morita, I., Nishi, H., and Murota, S. (1988). Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro. Prostaglandins Leukot. Essent. Fatty Acids 33, 81-87.
34. Watanabe, T., Yuki, S., Egawa, M., and Nishi, H. (1994). Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J. Pharmacol. Exp. Ther. 268, 1597-1604. (Pubitemid 24100383)
35. Yamamoto, Y., Kuwahara, T., Watanabe, K., and Watanabe, K. (1996). Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin- 5-one. Redox Report 2, 333-338.